文献速递脊柱关节炎其他结缔组织病

TNF抑制剂对炎症性肠病相关脊柱关节炎患者肠道菌群的影响

Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis.
PubMed 文献 · RMD Open · 2021-01-01

研究纳入20例未使用过生物制剂的肠病性关节炎患者,接受TNF抑制剂治疗6个月并坚持地中海饮食。治疗6个月后Lachnospiraceae科和Coprococcus属显著增加,Proteobacteria和Gammaproteobacteria呈下降趋势,Clostridia呈上升趋势;TNFi应答者与非应答者间alpha和beta多样性无差异。结论提示TNFi治疗倾向于恢复肠道真生态。

要点

  • TNFi治疗6个月后Lachnospiraceae科和Coprococcus属显著增加。
  • Proteobacteria和Gammaproteobacteria呈下降趋势,Clostridia呈上升趋势。
  • TNFi应答者与非应答者间alpha和beta多样性无差异。

核心结论

  • TNFi治疗6个月后肠道菌群变化与恢复肠道真生态的假设一致。

研究设计与样本

  • 研究纳入20例未使用过生物制剂的肠病性关节炎患者,接受TNFi治疗并在基线和6个月时自采粪便样本。
  • 所有患者遵循地中海饮食,采用NGS-based ITS和16S rRNA基因测序进行分类生物信息学分析。

主要发现

  • 治疗6个月后Lachnospiraceae科显著增加(Δ +10.3,p=0.04)。
  • 治疗6个月后Coprococcus属显著增加(Δ +2.8,p=0.003)。
  • Proteobacteria呈下降趋势(Δ -8.0,p=0.095),Gammaproteobacteria呈下降趋势(Δ -9,p=0.093),Clostridia呈上升趋势(Δ +8.2,p=0.083)。
  • TNFi应答者(SpA改善或IBD缓解)与非应答者在alpha和beta多样性上无差异。

临床怎么用

  • 对于IBD相关脊柱关节炎患者,TNFi治疗可能伴随肠道菌群向真生态方向变化。
  • TNFi对肠道菌群的影响与临床应答的关系尚不明确,应答者与非应答者多样性无差异。

局限性

  • 研究样本量较小(20例),且所有患者遵循地中海饮食,可能影响结果外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The close relationship between joints and gut inflammation has long been known and several data suggest that dysbiosis could link spondyloarthritis (SpA) to inflammatory bowel diseases (IBD). The introduction of biological drugs, in particular tumour necrosis factor inhibitors (TNFi), revolutionised the management of both these diseases. While the impact of conventional drugs on gut microbiota is well known, poor data are available about TNFi. AIM: To investigate the impact of TNFi on gut microbiota. METHODS: We evaluated 20 patients affected by enteropathic arthritis, naïve for biological drugs, treated with TNFi at baseline and after 6 months of therapy. All patients followed a Mediterranean diet. Patients performed self-sampling of a faecal sample at baseline and after 6 months of therapy. NGS-based ITS and 16S rRNA gene sequencing was performed, followed by the taxonomic bioinformatics analysis. RESULTS: After 6 months of therapy, we detected a remarkable increase in Lachnospiraceae family (Δ +10.3, p=0.04) and Coprococcus genus (Δ +2.8, p=0.003). We also noted a decreasing trend in Proteobacteria (Δ -8.0, p=0.095) and Gammaproteobacteria (Δ -9, p=0.093) and an increasing trend in Clostridia (Δ +8.2, p=0.083). We did not find differences between TNFi responders (SpA improvement or IBD remission achieved) and non-responders in terms of alpha and beta diversity. CONCLUSIONS: Our findings are consistent with the hypothesis that TNFi therapy tends to restore the intestinal eubiosis.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Ditto MC, Parisi S, Landolfi G, et al. Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis. RMD Open. 2021. PMID: 34489323. doi:10.1136/rmdopen-2021-001755

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。